| Reduced Risk Status: |
|
| IPM Compatibility: |
|
| Reasons for need: |
FOLIAR DISEASES
|
| Requesting State(s): |
MT:Burrows, M. ; TX:Ramezanpour, C. ;
|
| PCR Use Pattern: |
10.5-16 FL OZ/A; 1 FOLIAR APPLIC, BY GROUND OR AIR
|
| EPA Default Residue Trials: |
|
| IR-4 Residue Trial Plan: |
|
| Residue Protocol Use Pattern: |
|
| Efficacy/Crop Safety (E/CS) Data Required: |
NEED EFFICACY DATA
|
| E/CS Research Comments: |
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
AZOXYSTROBIN (QUADRIS) IS LABELED ON CANOLA, AND PROPICONAZOLE IS LABELED ON SUBGROUP 20A; IF THE DUAL AI PRODUCT QUILT XCEL IS LABELED, IT NEEDS TO SAY: RAPESEED INCLUDING VARIETIES SUCH AS CANOLA AND BRASSICA CARINATA:04/12; PRODUCT IS REGISTERED:05/14
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|